Cytomegalovirus reactivation in ICU patients
- 30 September 2015
- journal article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 42 (1) , 28-37
Abstract
Approximately 20 years have passed since we reported our results of histologically proven cytomegalovirus (CMV) pneumonia in non-immunocompromised ICU patients. Even if there are more recent reports suggesting that CMV may worsen the outcomes for ICU patients, there is no definite answer to this question: is CMV a potential pathogen for ICU patients or is it simply a bystander? We will describe the pathophysiology of active CMV infection and the most recent insights concerning the epidemiological aspects of these reactivations. Cytomegalovirus can be pathogenic by a direct organ insult (such as for the lung), by decreasing host defences against other microorganisms and/or by enhancing the body’s inflammatory response (as in acute respiratory distress syndrome). The incidence of active CMV infection is dependent on the diagnostic method used. Using the most sophisticated available biological tools, the incidence can reach 15–20 % of ICU patients (20–40 % in ICU patients with positive CMV serology). In adequately powered cohorts of patients, active CMV infection appears to be associated with worse outcomes for mechanically ventilated ICU patients. There is no absolute direct proof of a negative impact of active CMV infection on the health outcomes of mechanically ventilated patients. Prospective randomized trials are lacking. Future trials should examine the potential benefits for health outcomes of using antiviral treatments. Such treatments could be prophylactic, pre-emptive or used only when there is an end-organ disease. Cytomegalovirus infection may affect health outcomes for ICU patients. Additional prospective trials are necessary to confirm this hypothesis.Keywords
This publication has 52 references indexed in Scilit:
- Cytomegalovirus and Herpes Simplex Virus Effect on the Prognosis of Mechanically Ventilated Patients Suspected to Have Ventilator-Associated PneumoniaPLOS ONE, 2012
- Higher Immunoglobulin G Antibody Levels Against Cytomegalovirus Are Associated With Incident Ischemic Heart Disease in the Population-Based EPIC-Norfolk CohortThe Journal of Infectious Diseases, 2012
- Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsisCritical Care, 2011
- Is cytomegalovirus reactivation increasing the mortality of patients with severe sepsis?Critical Care, 2011
- Cytomegalovirus infection monitored by quantitative real-time PCR in critically ill patientsCritical Care, 2011
- Cytomegalovirus infection in critically ill patients: a systematic reviewCritical Care, 2009
- Cytomegalovirus Reactivation in Critically Ill Immunocompetent PatientsJAMA, 2008
- Active Cytomegalovirus Infection in Patients with Septic ShockEmerging Infectious Diseases, 2006
- Lipopolysaccharide, Tumor Necrosis Factor Alpha, or Interleukin-1β Triggers Reactivation of Latent Cytomegalovirus in Immunocompetent MiceJournal of Virology, 2006
- Severe Herpesvirus Infections in an Adolescent without Natural Killer CellsNew England Journal of Medicine, 1989